These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 12043424)

  • 1. [Marketing of the LIFE trial anticipates evaluation of the drug].
    Järhult B
    Lakartidningen; 2002 Apr; 99(17):1964. PubMed ID: 12043424
    [No Abstract]   [Full Text] [Related]  

  • 2. [Marketing of researchers--lack of judgment or a new trend?].
    Werkö L; Hernborg A; Liedholm H; Melander A
    Lakartidningen; 2002 Apr; 99(17):1962-3. PubMed ID: 12043423
    [No Abstract]   [Full Text] [Related]  

  • 3. Was the LIFE trial independent?
    Vandenbroucke JP
    Lancet; 2002 Oct; 360(9340):1171; author reply 1171. PubMed ID: 12387974
    [No Abstract]   [Full Text] [Related]  

  • 4. Was the LIFE trial independent?
    Van Brabandt H
    Lancet; 2002 Oct; 360(9340):1171; author reply 1171. PubMed ID: 12387973
    [No Abstract]   [Full Text] [Related]  

  • 5. [Rules of the game in drug marketing].
    Palva E
    Duodecim; 1999; 115(20):2187, 2189. PubMed ID: 11973920
    [No Abstract]   [Full Text] [Related]  

  • 6. [The LIFE study: extensive marketing in Denmark. Suggestions to conclusions based on the study].
    Lindberg M
    Lakartidningen; 2002 May; 99(20):2324. PubMed ID: 12082955
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cost-effectiveness of treatment of high blood pressure with losartan in Denmark].
    Keiding H; Hildebrandt P; Burke T; Carides GW
    Ugeskr Laeger; 2006 Oct; 168(42):3623-6. PubMed ID: 17069726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. More on the LIFE study.
    Vandenbroucke JP
    Lancet; 2003 Feb; 361(9356):532-3; author reply 533-4. PubMed ID: 12583976
    [No Abstract]   [Full Text] [Related]  

  • 9. Regulating manufacturer-affiliated communication in the information age.
    Schulman KA; Abernethy DR; Rathore SS; Woosley RL
    Clin Pharmacol Ther; 1999 Jun; 65(6):593-7. PubMed ID: 10391664
    [No Abstract]   [Full Text] [Related]  

  • 10. [Preventing stroke. Which antihypertensive drugs can do it better?].
    Böhm S
    MMW Fortschr Med; 2002 Jul; 144(29-30):14-5. PubMed ID: 12219605
    [No Abstract]   [Full Text] [Related]  

  • 11. More on the LIFE study.
    Werkö L
    Lancet; 2003 Feb; 361(9356):532; author reply 533-4. PubMed ID: 12583975
    [No Abstract]   [Full Text] [Related]  

  • 12. The not-so-hidden persuaders.
    Harv Heart Lett; 1999 Oct; 10(2):6-7. PubMed ID: 10534813
    [No Abstract]   [Full Text] [Related]  

  • 13. Selling drugs to the public--should the UK follow the example of the US?
    Frey J
    Br J Gen Pract; 2002 Feb; 52(475):170-1. PubMed ID: 11885831
    [No Abstract]   [Full Text] [Related]  

  • 14. [Results from the LIFE study: promising effects of new hypertensive agents].
    Nilsson P; Kahan T
    Lakartidningen; 2002 Apr; 99(16):1792-4. PubMed ID: 12043477
    [No Abstract]   [Full Text] [Related]  

  • 15. Potential mechanisms of stroke benefit favoring losartan in the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study.
    Devereux RB; Dahlöf B
    Curr Med Res Opin; 2007 Feb; 23(2):443-57. PubMed ID: 17288698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [German Hypertension League on the LIFE Study. New evaluation of AT1 receptor antagonists].
    Dominiak P; Zidek W
    MMW Fortschr Med; 2002 Sep; 144(38):47. PubMed ID: 12395703
    [No Abstract]   [Full Text] [Related]  

  • 17. The LIFE Trial in 2004.
    Beevers DG
    J Hum Hypertens; 2004 Jun; 18(6):365. PubMed ID: 15153931
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmaceutical advertising: from prospectus to marketing.
    Cambronero-Saiz B
    J Epidemiol Community Health; 2007 Apr; 61(4):366. PubMed ID: 17372300
    [No Abstract]   [Full Text] [Related]  

  • 19. [What are the consequences of the LIFE Study for general practice].
    Zidek W
    MMW Fortschr Med; 2002 Sep; 144(38):48. PubMed ID: 12395704
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmaceuticals and medical devices: business practices. End-of-year issue brief.
    Jones TM
    Issue Brief Health Policy Track Serv; 2008 Jan; ():1-32. PubMed ID: 18345554
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.